Statistically significant improvements in primary endpoint of ammonia control compared with placebo at 36 weeksClinically important changes ...
Enh3ance trial results indicate DTX301 reduces ammonia levels by 18% and supports dietary liberalization in patients with OTC deficiency.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results